Novartis Recalls Excedrin, Other Over-the-Counter Meds (NVS)

Drug maker Novartis AG (NYSE: NVS) has issued a recall notice for several of its popular over-the-counter medicines:

Novartis Consumer Health (NCH) is voluntarily recalling all lots of select bottle sizes of Excedrin® and NoDoz® products with expiry dates of December 20, 2014 or earlier as well as Bufferin® and Gas-X® Prevention® products with expiry dates of December 20, 2013 or earlier, in the United States.

NCH is taking this action as a precautionary measure, because the products may contain stray tablets, capsules, or caplets from other Novartis products, or contain broken or chipped tablets.

The recall is voluntary. The full announcement is available from the FDA website here.